- Home
- MIN vs OSUR Comparison
MIN vs OSUR Comparison
Compare MIN & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIN
- OSUR
- Stock Information
- Founded
- MIN 1988
- OSUR 2000
- Country
- MIN United States
- OSUR United States
- Employees
- MIN N/A
- OSUR N/A
- Industry
- MIN Trusts Except Educational Religious and Charitable
- OSUR Medical/Dental Instruments
- Sector
- MIN Finance
- OSUR Health Care
- Exchange
- MIN Nasdaq
- OSUR Nasdaq
- Market Cap
- MIN 310.1M
- OSUR 334.1M
- IPO Year
- MIN N/A
- OSUR 1986
- Fundamental
- Price
- MIN $2.72
- OSUR $4.13
- Analyst Decision
- MIN
- OSUR Buy
- Analyst Count
- MIN 0
- OSUR 3
- Target Price
- MIN N/A
- OSUR $6.67
- AVG Volume (30 Days)
- MIN 331.0K
- OSUR 459.6K
- Earning Date
- MIN 01-01-0001
- OSUR 11-05-2024
- Dividend Yield
- MIN 7.31%
- OSUR N/A
- EPS Growth
- MIN N/A
- OSUR N/A
- EPS
- MIN 0.08
- OSUR 0.36
- Revenue
- MIN N/A
- OSUR $273,535,000.00
- Revenue This Year
- MIN N/A
- OSUR N/A
- Revenue Next Year
- MIN N/A
- OSUR N/A
- P/E Ratio
- MIN $33.38
- OSUR $11.35
- Revenue Growth
- MIN N/A
- OSUR N/A
- 52 Week Low
- MIN $2.52
- OSUR $3.92
- 52 Week High
- MIN $2.88
- OSUR $8.45
- Technical
- Relative Strength Index (RSI)
- MIN 44.73
- OSUR 45.49
- Support Level
- MIN $2.70
- OSUR $4.00
- Resistance Level
- MIN $2.74
- OSUR $4.16
- Average True Range (ATR)
- MIN 0.02
- OSUR 0.08
- MACD
- MIN -0.00
- OSUR 0.01
- Stochastic Oscillator
- MIN 22.89
- OSUR 57.89
About MIN MFS Intermediate Income Trust
MFS Intermediate Income Trust is a diversified closed-end management investment company. The fund's investment objective is to seek high current income but may also consider capital appreciation. It invests the assets in debt instruments. Its portfolio of investments comprises of different sector investments such as the automotive, chemicals, energy, food and beverages, insurance, and other sectors.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.